Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01442844 · ClinicalTrials.gov registry record · NA
Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01442844: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT01442844 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01442844, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study evaluates a novel micrografting technique to see how it will influence the healing rate and cosmetic result of second intention wounds. The graft harvesting and micrografting process was designed by MoMelan Technologies The Epidermal Expansion System, which is composed of a commercially available Blister Generation Device and the Microblister Generation and Excision Device (MBGED), will generate an array of small microblisters and transfer the micrografts to a sterile dressing (Tegaderm™ - an FDA approved wound dressing) for application to the subject's surgical area. The investigators predict that applying expanded micrografts to wounds that otherwise would have healed by second intention alone will hasten healing and possible reduce scarring.
Interventions
- DEVICE Micrografting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01442844
The ClinicalTrials.gov registry entry for NCT01442844 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micrografting is the first listed.
NCT01442844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01442844 about?
NCT01442844 is a clinical study titled "Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery". This study evaluates a novel micrografting technique to see how it will influence the healing rate and cosmetic result of second intention wounds. The graft harvesting and micrografting process was designed by MoMelan Technologies The Epidermal Expansion System, which is composed of a commercially a...
What is the current status of trial NCT01442844?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2011-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01442844?
The interventions under investigation include: Micrografting (DEVICE).
Who is sponsoring clinical trial NCT01442844?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.